RDEA3170 and Febuxostat Combination Study in Gout Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
This is a Phase 2a, randomized, open-label, multicenter study to assess the pharmacodynamic (PD) effects and safety of RDEA3170 administered in combination with febuxostat compared to febuxostat administered alone in adult subjects with gout.
Epistemonikos ID: 1626162fffeff53dcbee9f92570ece4aefc8d4ac
First added on: May 12, 2024